The total return over the past 12 months is +55.74% vs. +19.98% for the S&P 500. So far it's up +7.47% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +54.76% | +27.21% | +34.65% | +31.05% | +25.86% | +16.30% |
| Total Return CAGR | +55.74% | +28.08% | +35.87% | +33.11% | +28.66% | +19.62% |
| Revenue CAGR | +49.58% | +39.22% | +24.42% | +14.48% | +8.35% | +8.69% |
| Net Income CAGR | +93.55% | +60.17% | +34.49% | +26.91% | +12.24% | +11.28% |
| EPS CAGR | +94.34% | +51.83% | +28.88% | +26.56% | +11.36% | +13.52% |
| Free Cash Flow CAGR | N/A | +84.12% | +32.91% | +27.16% | +8.77% | +23.25% |
| Operating Cash Flow CAGR | +156.75% | +65.81% | +31.68% | +24.69% | +9.49% | +16.27% |
| Dividends CAGR | +15.40% | +15.24% | +15.18% | +11.61% | +7.74% | +7.11% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Eli Lilly and Company (LLY)
| Year | Start price | End price | LLY Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1,074.68 | $1,149.36 | +7.47% | +13.55% | (6.08%) |
| 2025 | $772.00 | $1,074.68 | +40.23% | +17.72% | +22.51% |
| 2024 | $582.92 | $772.00 | +33.30% | +24.89% | +8.41% |
| 2023 | $365.84 | $582.92 | +60.91% | +26.19% | +34.72% |
| 2022 | $276.22 | $365.84 | +34.24% | (18.17%) | +52.41% |
| 2021 | $168.84 | $276.22 | +66.08% | +28.74% | +37.34% |
| 2020 | $131.43 | $168.84 | +31.06% | +18.37% | +12.69% |
| 2019 | $115.72 | $131.43 | +16.15% | +31.22% | (15.07%) |
| 2018 | $84.46 | $115.72 | +40.45% | (4.56%) | +45.01% |
| 2017 | $73.55 | $84.46 | +17.83% | +21.70% | (3.87%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
